Health Ministry Takes Steps Toward Public Introduction of HPV Vaccine. Namibia’s Ministry of Health and Social Services has begun the procurement process for the human papillomavirus (HPV) vaccine, a crucial step toward combating cervical cancer. Executive Director Ben Nangombe confirmed that the ministry is navigating the necessary regulatory and compliance processes to make the vaccine available to the public.
“The product has been identified for use in Namibia, and procurement has commenced,” Nangombe stated. This marks a significant move to address cervical cancer, a preventable but life-threatening condition often linked to HPV infections.
Currently, the HPV vaccine is only available in Namibia’s private hospitals, requiring medical aid coverage. Dr. Ilona Sheehama, a specialist at Oshakati Intermediate Hospital, highlighted this limitation during an informative session on cervical cancer held at the hospital. Sheehama noted the absence of the vaccine in public health facilities but commended the ministry’s efforts to make it more accessible to the general population.
The HPV vaccine offers protection against certain strains of the virus known to cause various cancers, including cervical cancer. According to Dr. Sheehama, it is recommended for both boys and girls to provide widespread immunity. The vaccine is typically administered in two or three doses, depending on the age of the recipient.
By making the HPV vaccine publicly available, Namibia aims to improve health equity and protect its population from preventable diseases. The move aligns with global public health goals to reduce cervical cancer rates, especially in regions where access to preventive healthcare remains a challenge.
The ministry’s efforts reflect its commitment to enhancing healthcare services and prioritizing preventive measures to reduce the burden of cervical cancer on the country’s healthcare system.